Mr. Donald Jones
Chief Digital Officer at Scripps Translational Science Institute, Cardiff Ocean Group Chairman
Donald Jones serves as an independent board member for health-related companies. He sits on multiple Fortune 1000 Advisory Boards. He advises on digital heath, the Internet of Medical Things, and technology-enabled services. He is globally recognized for his expertise in wireless technologies, mobility and network effect for fitness, health and health care products, apps, services, and therapies.
Editor Emeritus of Modern Healthcare
Merrill Goozner, Editor Emeritus of Modern Healthcare, served as Editor of the nation’s leading health care trade journal from December 2012 to April 2017. As Editor Emeritus, he continues to write a weekly column as well as serve as a speaker and moderator at Modern Healthcare conferences and events.
While editor, he provided overall editorial direction and oversaw editorial content for Modern Healthcare magazine, its newsletters and website. Prior to joining Modern Healthcare, his journalism career spanned nearly 40 years as an editor, writer, and journalism educator. In 2004, he authored The $800 Million Pill: The Truth Behind the Cost of New Drugs (University of California Press). He has served as a foreign, national, and chief economics correspondent for the Chicago Tribune; a professor of journalism at New York University; and has contributed to numerous publications over the course of his career, including the New York Times, the American Prospect, JAMA Internal Medicine, and the Journal of the National Cancer Institute.
He earned his master’s degree in journalism from Columbia University in 1982 and his Bachelor of Arts degree in history from the University of Cincinnati in 1975. The U. of C. named him one of its Distinguished Alumni in 2008 and inducted him into its Journalism Hall of Fame in 2016.
Goozner and wife Karen have three children and three grandchildren.
Founding Member of Prevision Policy LLC
Michael McCaughan is a founding member of Prevision Policy LLC, a leading provider of regulatory and reimbursement policy analysis for the biopharma industry. He previously was the Editor-In-Chief of The Pink Sheet and remains a contributor to the publication. McCaughan speaks frequently on regulatory, reimbursement, and policy developments affecting the biopharmaceutical industry.